Inviting the right people to the party: Model practice for state-wide engagement to prevent diabetes
The American Medical Association (AMA) is committed to improve the public health of the nation by bringing physicians together with communities, and public and private sector organizations to prevent and achieve measurable improvements in health outcomes, particularly as it related to prediabetes. This long-term commitment focuses on health outcomes, improving medical care, and on strengthening links between the clinic and community through novel strategies and collaborations.
To actively address the prediabetes epidemic, the AMA and the National Association of Chronic Disease Directors (NACDD) embarked upon a strategic initiative at the state level, beginning in the state of Michigan. This multipronged approach seeks to achieve greater stakeholder engagement while also ensuring action and sustainability.
This session will provide an overview of the Michigan initiative; describe a model of state engagement that includes traditional and nontraditional stakeholders from various sectors coming together for a state-wide meeting; report on the action plan that came as a result of the meeting; and describe how the AMA and NACDD are continuing to work with the state of Michigan and beyond to foster continued progress.
Learning Areas:Chronic disease management and prevention
Define the AMA state-wide diabetes prevention initiative. Describe the strategy for stakeholder selection. Explain the current status of this state engagement initiative.
Keyword(s): Diabetes, Chronic Disease Prevention
Qualified on the content I am responsible for because: As a member of the AMA's Improving Health Outcomes team for over three years, I am a Project Manager on the AMA Diabetes Prevention initiative and work closely with the AMA's state engagement efforts.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.